Publicação
Protonectin peptides target lipids, act at the interface and selectively kill metastatic breast cancer cells while preserving morphological integrity
| dc.contributor.author | Batista Martins, Danubia | |
| dc.contributor.author | Fadel, Valmir | |
| dc.contributor.author | Oliveira, Filipa D. | |
| dc.contributor.author | Gaspar, Diana | |
| dc.contributor.author | Alvares, Dayane S. | |
| dc.contributor.author | Castanho, Miguel A. R. B. | |
| dc.contributor.author | Dos Santos Cabrera, Marcia Perez | |
| dc.date.accessioned | 2021-07-19T12:21:04Z | |
| dc.date.available | 2021-07-19T12:21:04Z | |
| dc.date.issued | 2021-05-25 | |
| dc.description | © 2021 Elsevier Inc. All rights reserved. | pt_PT |
| dc.description.abstract | Despite the need for innovative compounds as antimicrobial and anticancer agents, natural sources of peptides remain underexplored. Protonectin (PTN), a cationic dodecapeptide of pharmacological interest, presents large hydrophobicity that is associated with the tendency to aggregate and supposedly influences bioactivity. A disaggregating role was assigned to PTN' N-terminal fragment (PTN1-6), which enhances the bioactivity of PTN in a 1:1 mixture (PTN/PTN1-6). Spectroscopic techniques and model membranes (phospholipid bilayers and SDS micelles) revealed that environment-dependent aggregation is reduced for PTN/PTN1-6, but cytotoxicity of PTNs on MDA-MB-231 breast cancer showed the same CC50 values around 16 µM and on MCF-10A epithelial breast cells 6 to 5-fold higher values, revealing a selective interaction. Since PTN1-6 lacks activity on breast cells, its presence should differently affect PTN activity, suggesting that aggregation could modulate activity depending on the membrane characteristics. Indeed, increased partitioning and lytic activity of PTN/PTN1-6 were found in model membranes independently of charge density, but affected by the curvature tendency. PTN and PTN/PTN1-6 do not alter morphology and roughness of cancer cells, indicating a superficial interaction with membranes and consistent with results obtained in NMR experiments. Our results indicate that aggregation of PTNs depends on the membrane characteristics and modulates the activity of the peptides. | pt_PT |
| dc.description.sponsorship | This work was supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo – FAPESP [Funding Projects Nos. 2012/24259-0, 2014/08372-7, 2016/50178-8] and Fundação para a Ciência e a Tecnologia, Portugal – FCT I. P. [Funding PTDC/BBB-BQB/1693/2014]. DSA has a postdoctoral fellowship (FAPESP grant# 2015/25620-7) and also thanks CAPES for former scholarships. DBM and FDO acknowledge, respectively, CAPES scholarships and FCT I.P. fellowship [PD/BD/135046/2017]. The Brazilian BioscienceNational Laboratory (LNBio) is acknowledged for the NMR timemachine [proposal RMN-23300]. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | J Colloid Interface Sci. 2021 May 25;601:517-530 | pt_PT |
| dc.identifier.doi | 10.1016/j.jcis.2021.05.115 | pt_PT |
| dc.identifier.eissn | 1095-7103 | |
| dc.identifier.issn | 0021-9797 | |
| dc.identifier.uri | http://hdl.handle.net/10451/48991 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Elsevier | pt_PT |
| dc.relation | Cell-cell communication in metastatic breast cancer: a control point that can lead to breast cancer treatment | |
| dc.relation | Exosomes as drug delivery systems in metastatic breast cancer | |
| dc.relation.publisherversion | https://www.sciencedirect.com/journal/journal-of-colloid-and-interface-science | pt_PT |
| dc.subject | AFM | pt_PT |
| dc.subject | Aggregation | pt_PT |
| dc.subject | Anticancer activity | pt_PT |
| dc.subject | Breast cancer cells | pt_PT |
| dc.subject | Model membranes | pt_PT |
| dc.subject | NMR structure | pt_PT |
| dc.subject | Peptide-membrane surface interaction | pt_PT |
| dc.subject | Protonectin | pt_PT |
| dc.title | Protonectin peptides target lipids, act at the interface and selectively kill metastatic breast cancer cells while preserving morphological integrity | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | Cell-cell communication in metastatic breast cancer: a control point that can lead to breast cancer treatment | |
| oaire.awardTitle | Exosomes as drug delivery systems in metastatic breast cancer | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FBBB-BQB%2F1693%2F2014/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT//PD%2FBD%2F135046%2F2017/PT | |
| oaire.citation.endPage | 530 | pt_PT |
| oaire.citation.startPage | 517 | pt_PT |
| oaire.citation.title | Journal of Colloid and Interface Science | pt_PT |
| oaire.citation.volume | 601 | pt_PT |
| oaire.fundingStream | 3599-PPCDT | |
| person.familyName | Castanho | |
| person.givenName | Miguel | |
| person.identifier.orcid | 0000-0001-7891-7562 | |
| person.identifier.scopus-author-id | 56605575600 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | f5e46f85-fabf-450a-9ee2-1c7b59410892 | |
| relation.isAuthorOfPublication.latestForDiscovery | f5e46f85-fabf-450a-9ee2-1c7b59410892 | |
| relation.isProjectOfPublication | 1d62ccb1-a760-46c2-86e0-e3e40d41a318 | |
| relation.isProjectOfPublication | f5fbfaa0-4654-4e9e-8d71-7bf0ed5539d5 | |
| relation.isProjectOfPublication.latestForDiscovery | 1d62ccb1-a760-46c2-86e0-e3e40d41a318 |
Ficheiros
Principais
1 - 1 de 1
Miniatura indisponível
- Nome:
- Protonectin_peptides.pdf
- Tamanho:
- 3.24 MB
- Formato:
- Adobe Portable Document Format
